Life-threatening @entity548 with @entity2702 and XXXX .

@entity1 @entity2702 @entity548 @entity1884
The occurrence of significant @entity548 associated with @entity2702 ( @entity2702 ) and @entity1884 ( @entity1884 ) and the incidence of @entity2702 in family members of @entity1 with @entity2702 and @entity1884 are poorly defined. We reviewed our experience in 143 @entity1 with @entity2702 and @entity1884 . Eleven (8 percent) of the 143 @entity1 with @entity1884 and @entity2702 had a history of either massive hemoptysis or of hemothorax which required hospitalization. One @entity1 died directly related to the @entity548 . There were four @entity1 and seven @entity1 . Three of the seven @entity1 experienced @entity548 during pregnancy. Seven of the 11 families participated in screening for @entity2702 . Thirty-six (80 percent) of the 45 screened family members were found to have @entity1884 . Thirteen (36 percent) of the 36 family members with @entity1884 were proven to have @entity2702 by pulmonary angiography. @entity548 due to spontaneous rupture of the PAVM is a potentially life-threatening complication that should be treated aggressively with transcatheter embolotherapy. It occurs more frequently than previously recognized in @entity1 with @entity2702 and @entity1884 . In addition, because of the increased incidence of @entity2702 in family members of @entity1 with @entity1884 and PAVM, screening of family members with @entity1884 is recommended especially in @entity1 of childbearing age.
